Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-beach crawled time : 15:20 save search
Avidity Biosciences to Host Investor and Analyst Event Focused on AOC 1001 Topline Data from Phase 1/2 MARINA™ Trial on April 27, 2023
Published: 2023-04-13 (Crawled : 15:20) - biospace.com/
RNA | $24.005 0.4% 530K
|
Health Technology
|
| O: 1.43%
H: 8.32%
C: 7.54%
topline trial
ATEC to Report First Quarter 2023 Financial Results on May 4, 2023
Published: 2023-04-13 (Crawled : 15:20) - biospace.com/
ATEC | $13.065 -0.27% 490K
|
Health Technology
|
| O: 0.52%
H: 2.45%
C: 1.93%
report financial results
Regulus Therapeutics Announces $15 Million Private Placement of Equity
Published: 2023-04-13 (Crawled : 15:20) - biospace.com/
RGLS | $2.56 -7.91% 400K
|
Health Technology
|
| O: 12.21%
H: 33.65%
C: 20.79%
therapeutics
Daré Bioscience Reports Full Year 2022 Financial Results and Provides a Company Update
Published: 2023-03-30 (Crawled : 15:20) - biospace.com/
DARE | $0.48 -0.02% 82K
|
Health Technology
|
| O: -1.92%
H: 5.88%
C: 3.92%
year bioscience update financial results
Skye Bioscience Receives Human Research Ethics Committee Approval to Start Multiple Ascending Dose Arm of Phase 1 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-03-15 (Crawled : 15:20) - biospace.com/
SKYE | $9.17 -20.98% 27K
|
Transportation and Warehousing
|
| O: -3.85%
H: 8.0%
C: 1.2%
sbi-100 arm approval bioscience research study phase 1
Nexcella, Inc. Presents 42-Patient Interim Data, with 90% Overall Response Rate in Relapsed or Refractory Multiple Myeloma at NXC-201 Therapeutic Dose from its Phase 1 Expansion Trial at the 5th European CAR T-cell Meeting
Published: 2023-02-09 (Crawled : 15:20) - biospace.com/
IMMX | $2.55 -4.14% 230K
|
|
| O: -5.14%
H: 4.53%
C: -12.08%
nxc-201 expansion meeting t-cell trial response
STAND UP TO CANCER ANNOUNCES FOUR TEAMS FOCUSED ON DIVERSITY IN EARLY PHASE CANCER CLINICAL TRIALS
Published: 2023-02-08 (Crawled : 15:20) - biospace.com/
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: -0.06%
H: 0.77%
C: 0.19%
trials cancer
Ligand’s Partner Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Published: 2023-01-06 (Crawled : 15:20) - biospace.com/
NOVN | $0.0941 -24.84% -32.91% 7.2M
|
Health Technology
|
| O: 0.0%
H: 1.96%
C: -26.96%
LGND | $81.4 2.04% 68K
|
Health Technology
|
| O: 0.59%
H: 1.57%
C: 0.17%
sb206 molluscum treatment fda drug application
Nexcella, Inc. Announces Additional Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in Relapsed/Refractory AL Amyloidosis Patients, Duration of Response Not Yet Reached
Published: 2023-01-06 (Crawled : 15:20) - biospace.com/
IMMX | $2.55 -4.14% 230K
|
|
| O: -11.76%
H: 12.44%
C: 4.0%
nxc-201 response positive
ImmixBio Ships Tislelizumab for Patient Dosing in its Combination Clinical Trial with IMX-110 in Advanced Solid Tumors
Published: 2022-12-19 (Crawled : 15:20) - biospace.com/
IMMX | $2.55 -4.14% 230K
|
|
| O: -8.47%
H: 35.84%
C: 13.87%
imx-110 trial tumors
Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% for Expanded Indication for the Treatment of Plaque Psoriasis in Children Down to 2 Years of Age
Published: 2022-12-19 (Crawled : 15:20) - biospace.com/
ARQT A | $10.06 -0.3% 1M
|
Health Technology
|
| O: -0.75%
H: 1.01%
C: -7.01%
zoryve treatment drug children application psoriasis
eFFECTOR Therapeutics to Present at JMP Securities Life Sciences Conference
Published: 2022-06-07 (Crawled : 15:20) - biospace.com/
EFTR | $1.99 3.11% 200K
|
|
| O: 0.72%
H: 1.43%
C: -7.14%
sciences conference life therapeutics
Singular Genomics and Olink Collaborate to Enable Olink® Explore on the G4 Max Read™ Sequencing Kits
Published: 2022-06-07 (Crawled : 15:20) - biospace.com/
OLK | $22.73 -0.04% 360K
|
Manufacturing
|
| O: -1.86%
H: 0.0%
C: 0.0%
OMIC | $0.3879 2.89% 290K
|
Professional, Scientific, and T...
|
| O: -2.19%
H: 7.99%
C: 7.67%
olink genomics
Lantronix Contributes to Creation of EchoNous AI-Assisted Handheld Ultrasound DeviceCase Study: Open-Q Micro SOM, Development Kit and Engineering Services
Published: 2022-06-07 (Crawled : 15:20) - biospace.com/
QCOM | $168.0 -1.08% 3.5M
|
Electronic Technology
|
| O: -0.93%
H: 2.17%
C: 1.98%
LTRX | $3.26 3.16% 120K
|
Distribution Services
|
| O: -1.01%
H: 4.93%
C: 4.25%
services
Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
Published: 2022-06-03 (Crawled : 15:20) - biospace.com/
OMIC | $0.3879 2.89% 290K
|
Professional, Scientific, and T...
|
| O: -1.75%
H: 2.08%
C: -0.89%
conference genomics
Sorrento Therapeutics Announces First Subject Dosed in a Phase I Clinical Study of STI-1558, an Oral Mpro Inhibitor as a Standalone Treatment and Prevention of COVID-19 Without Co-Administration of Ritonavir Booster
Published: 2022-06-03 (Crawled : 15:20) - biospace.com/
SRNE | $0.033 2M
|
Health Technology
|
| O: 8.18%
H: 2.33%
C: -0.58%
sti-1558 covid-19 treatment therapeutics
Oscars Slap Shines New Spotlight on Alopecia Areata
Published: 2022-03-30 (Crawled : 15:20) - biospace.com/
ARQT A | $10.06 -0.3% 1M
|
Health Technology
|
| O: 0.05%
H: 4.81%
C: 1.57%
ANAB | $21.45 0.85% 88K
|
Health Technology
|
| O: 0.08%
H: 1.02%
C: -3.5%
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
WISA 4 | $5.33 204.57% 190M
|
Electronic Technology
TPET | $0.5189 124.54% 38M
|
n/a
SXTC | $1.78 52.14% 33M
|
Health Technology
JAGX | $0.1771 49.07% 540M
|
Health Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
FNCH | $2.98 32.74% 400K
|
Professional, Scientific, and T...
PALI | $5.51 32.45% 28M
|
Manufacturing
VERO | $0.804 31.8% 110K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.